⌘K

Login Start Free

Home/Filings/4/0001144204-17-037014

4//SEC Filing

ARBEL IRIT 4

Accession 0001144204-17-037014

CIK 0001137883other

View on SEC.gov Company Profile

Filed

Jul 16, 8:00 PM ET

Accepted

Jul 17, 5:01 PM ET

Size

5.6 KB

Accession

0001144204-17-037014

Insider Transaction Report

Form 4

Period: 2017-07-13

BRAINSTORM CELL THERAPEUTICS INC.BCLI

Director

Transactions

Award
Stock Option (right to buy)
2017-07-13+12,000→ 12,000 total
Exercise: $0.75From: 2018-07-13Exp: 2028-07-13→ Common Stock (12,000 underlying)

Footnotes (1)

[F1]Option is fully vested and exercisable on the date of grant.

Documents

1 file

4
v470752_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

BRAINSTORM CELL THERAPEUTICS INC.

CIK 0001137883

Entity typeother

Related Parties

1

filerCIK 0001245607

Filing Metadata

Form type: 4
Filed: Jul 16, 8:00 PM ET
Accepted: Jul 17, 5:01 PM ET
Size: 5.6 KB

View on SEC.gov